AC
CELG

Athos Capital’s Celgene Corp CELG Stock Holding History

Athos Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-221,964
Closed -$22M – 48
2019
Q3 		$22M Buy
221,964
+33,633
+18% +$3.2M 21.62% 1
2019
Q2 		$17.4M Buy
188,331
+16,576
+10% +$1.57M 7.68% 4
2019
Q1 		$16.2M Buy
+171,755
New +$15M 10.44% 4

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Athos Capital's CELG Position: Q4 2019 in Review

Athos Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 221,964 shares — an estimated $22M sold.

Athos Capital first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $22M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Athos Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Athos Capital sold 221,964 Celgene Corp shares in Q4 2019, an estimated $22M.
  • Athos Capital first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
  • Athos Capital's Celgene Corp position peaked at $22M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Athos Capital's 13F filing for Q4 2019, filed 11 Feb 2020.